The Jumpstart Our Business Startups (JOBS) Act has had an extremely positive influence on the growth prospects for emerging biotechnology companies since it came into being in 2012. In fact, there has been a tidal wave of companies who have successfully completed their initial public offerings (IPOs) since its introduction.